Squamous cell carcinoma is not on the VA’s list of conditions presumed to be caused by Agent Orange, so an Agent Orange squamous cell carcinoma VA claim has to be built on direct evidence: a confirmed diagnosis, proof of qualifying service, and a medical opinion tying the cancer to herbicide exposure. Veterans have won these claims. The path is harder than a presumptive claim, and the quality of the nexus evidence is almost always what decides it.
Why Squamous Cell Carcinoma Is Not Presumptive
The VA’s Agent Orange presumptive list covers bladder cancer, prostate cancer, respiratory cancers (lung, larynx, trachea, and bronchus), non-Hodgkin’s lymphoma, Hodgkin’s disease, multiple myeloma, chronic B-cell leukemias, and certain soft tissue sarcomas, along with non-cancer conditions like type 2 diabetes, ischemic heart disease, Parkinson’s disease, and chloracne.1U.S. Department of Veterans Affairs. Agent Orange Diseases Squamous cell carcinoma, whether of the skin, oral cavity, tonsil, or elsewhere, is not on it. The PACT Act of 2022 expanded the presumptive list but added only hypertension and monoclonal gammopathy of undetermined significance for Agent Orange; no skin or head-and-neck cancers were added.2U.S. Department of Veterans Affairs. Agent Orange Exposure and VA Disability Compensation
The most recent comprehensive scientific review, the National Academies’ Veterans and Agent Orange: Update 11 (2018), classified the evidence linking Agent Orange to non-melanoma skin cancer as “inadequate or insufficient to determine whether there is an association.”3National Academies of Sciences, Engineering, and Medicine. Veterans and Agent Orange: Update 11 (2018) – Summary That classification has not been upgraded.
The practical effect: a veteran with a presumptive condition does not have to prove causation. For squamous cell carcinoma, you do.
What You Have to Prove
The VA calls it “direct service connection,” and it requires three pieces of documentation:
- A confirmed medical diagnosis of squamous cell carcinoma.
- Military records, typically a DD214, showing service in a location and period that qualifies for the presumption of herbicide exposure (Vietnam between January 9, 1962 and May 7, 1975, or qualifying service in Thailand, Laos, or near the Korean DMZ during specified periods).
- Nexus evidence, meaning a medical opinion connecting the cancer to that exposure, supported by scientific literature.2U.S. Department of Veterans Affairs. Agent Orange Exposure and VA Disability Compensation
If you served in a qualifying location, you don’t have to prove you personally handled or were sprayed with Agent Orange. Exposure is presumed. What you still have to prove is that the cancer itself is connected to that exposure. That’s the nexus.
The federal appeals court confirmed in Combee v. Brown (1994) that a veteran can win service connection through direct proof of causation even when a condition is not on the presumptive list. Every successful squamous cell carcinoma claim runs through that door.
What Makes a Nexus Letter Work
Board of Veterans’ Appeals decisions show a consistent pattern in which nexus opinions get credited and which get dismissed. The successful ones share several features:
- They use the VA’s legal standard, stating the cancer is “at least as likely as not” caused by herbicide exposure. Words like “possible” or “may have a relationship” get rejected as speculative.
- They cite specific medical literature linking TCDD, the dioxin in Agent Orange, to the veteran’s cancer type.
- They address the individual veteran and rule out competing causes. Non-smoking status and no alcohol use are repeatedly cited by the Board when granting head-and-neck cancer claims.
- They come from a treating specialist, typically an oncologist or dermatologist, rather than a general practitioner.
A 2003 denial for squamous cell carcinoma of the face is the textbook example of what fails. The veteran’s physicians used equivocal language and provided no clinical data or scientific rationale, and the Board rejected the opinions as speculative.4Board of Veterans’ Appeals. BVA Citation Nr: 0306446 The scientific evidence available to veterans today is substantially stronger than what was on the record in 2003.
The Scientific Evidence You Can Cite
The toxic contaminant in Agent Orange is 2,3,7,8-tetrachlorodibenzo-p-dioxin, or TCDD. The International Agency for Research on Cancer classifies TCDD as a Group 1 carcinogen, meaning a known human carcinogen.5IARC. IARC Summary and Evaluation – 2,3,7,8-TCDD TCDD binds to the aryl hydrocarbon receptor and alters gene expression, cell growth, and differentiation, while also inhibiting apoptosis, the body’s process for killing abnormal cells. Its half-life in humans is roughly 6 to 11 years, so it accumulates in tissue.6National Toxicology Program. TCDD – Report on Carcinogens
Animal studies have directly linked TCDD to squamous cell carcinomas. In rat feeding studies, TCDD produced squamous cell carcinomas of the tongue, hard palate, nasal turbinates, and lung. In hamsters, TCDD caused squamous cell carcinomas of the skin.5IARC. IARC Summary and Evaluation – 2,3,7,8-TCDD
Three human studies have been particularly useful in winning VA claims:
Clemens et al. (2014). A pilot study at MD Anderson published in Plastic and Reconstructive Surgery reviewed 100 men in the Agent Orange registry at the VA Hospital in Washington, D.C. Non-melanoma invasive skin cancer was found in 51% of TCDD-exposed veterans, more than double the 23.8% expected rate for age-matched men. Among veterans who had actively sprayed Agent Orange, the rate was 73%; among those who also had chloracne, it exceeded 80%.7PubMed. Association Between Agent Orange Exposure and Nonmelanotic Invasive Skin Cancer8American Society of Plastic Surgeons. Agent Orange Linked to Skin Cancer Risk
Mowery, Conlin, and Clayburgh (2020). Published in Oral Oncology, this study analyzed VA records for nearly 8.9 million Vietnam-era veterans. Among those reporting Agent Orange exposure, relative risk was 1.10 for upper aerodigestive tract carcinoma, 1.24 for thyroid cancer, 1.22 for nasopharyngeal, 1.16 for oropharyngeal, and 1.11 for laryngeal cancer.9PubMed. Increased Risk of Head and Neck Cancer in Agent Orange Exposed Vietnam Era Veterans
Yi and Ohrr (2014). A study of more than 180,000 Korean Vietnam War veterans published in Cancer found an adjusted hazard ratio of 2.54 for oral cavity cancer in the high-exposure group. When restricted to microscopically confirmed oral squamous cell carcinoma, the hazard ratio was 2.94.10Wiley Online Library. Agent Orange Exposure and Cancer Incidence in Korean Vietnam Veterans
A 2024 systematic review and meta-analysis in the World Journal of Otorhinolaryngology — Head and Neck Surgery pooled 13 studies covering nearly 8.9 million patients and confirmed that head and neck cancer was significantly more common among Agent Orange-exposed individuals, and that exposed individuals were more likely to die from the disease.11PubMed Central. Head and Neck Cancer in Agent Orange-Exposed Populations – Systematic Review
How Past BVA Decisions Have Come Out
Individual Board decisions don’t create binding precedent, but they show how the same evidence gets weighed.
December 2004. The Board granted service connection for squamous cell carcinoma of the head and neck (posterior pharynx, lateral pharyngeal wall, supraglottic area) in a Vietnam veteran. It gave “great weight” to opinions from the veteran’s private head-and-neck specialists, who emphasized that the veteran did not use tobacco or alcohol and called the cancer’s development without those risk factors “highly unusual.” One physician stated “with a high degree of certainty” that Agent Orange caused the cancer.12Board of Veterans’ Appeals. BVA Citation Nr: 0433443
November 2016. The Board granted service connection for squamous cell carcinoma of the left tonsil. It acknowledged tonsillar cancer does not qualify as a “respiratory cancer” under the presumptive list but found sufficient evidence for direct causation. A VA examiner and a private physician both opined the cancer was “at least as likely as not” related to Agent Orange, and the veteran’s non-smoking status supported the claim.13Board of Veterans’ Appeals. BVA Citation Nr: 1643698
January 2023. The Board granted service connection for oral squamous cell carcinoma, overturning a regional office denial. A physician cited the Mowery study; a VA examiner argued that the veteran’s 40-year tobacco history was the more likely cause. The Board found the evidence in “equipoise” and applied the benefit-of-the-doubt rule in the veteran’s favor.14Board of Veterans’ Appeals. BVA Citation Nr: A23001203
March 2025. The Board granted service connection for squamous cell carcinoma of the skin (along with melanoma and basal cell carcinoma). A private dermatologist opined it was “more likely than not” that Agent Orange contributed, and a VA examiner agreed. The Board noted that distinguishing between sun exposure and herbicide exposure as causes was “of no consequence” because both were service-related.15Board of Veterans’ Appeals. BVA Citation Nr: A25026747
The through-line: specialist opinions, the correct legal phrasing, cited literature, and a documented reason competing causes don’t fit.
The Chloracne Secondary Route
Chloracne is on the Agent Orange presumptive list. The Clemens study found that veterans with chloracne had a non-melanoma skin cancer rate exceeding 80%.7PubMed. Association Between Agent Orange Exposure and Nonmelanotic Invasive Skin Cancer If you already have a chloracne rating, you may be able to claim squamous cell carcinoma as secondary to that service-connected condition, which the VA allows when a new condition is caused or aggravated by an existing one. A physician’s nexus letter tracing the progression from chronic dioxin-related skin damage to squamous cell carcinoma, supported by the Clemens data, is the core of that theory.
If You Win: How the Rating Works
Service-connected squamous cell carcinoma is rated under Diagnostic Code 7818 (malignant skin neoplasms other than melanoma) in 38 C.F.R. § 4.118.16eCFR. 38 CFR § 4.118 – Schedule of Ratings, Skin
If treatment is comparable to systemic malignancy therapy (systemic chemotherapy, extensive radiation beyond the skin, or surgery more extensive than wide local excision), the veteran receives a temporary 100% rating that runs from the start of treatment through a mandatory VA examination six months after treatment ends. After that, the rating is based on residuals: local recurrence, metastasis, or scarring and disfigurement.17Cornell Law Institute. 38 CFR § 4.118 – Skin Diagnostic Codes
If treatment stays confined to the skin (excision, cryotherapy, or topical chemotherapy), the 100% temporary rating does not apply. The VA rates the residuals as scars, using diagnostic codes for disfigurement of the head, face, or neck, painful or unstable scars, or scars with underlying soft tissue damage. Ratings run from 10% to 40% depending on size and severity.18Board of Veterans’ Appeals. BVA Citation Nr: A20000005
If a prior claim for squamous cell carcinoma was denied, a Supplemental Claim can reopen it on the strength of new evidence, whether a stronger nexus letter or newly published research.2U.S. Department of Veterans Affairs. Agent Orange Exposure and VA Disability Compensation The 2003 denial cited above was decided on a record that predates every major study discussed here. The evidentiary landscape is not what it was.